Inventor · disambiguated record
Alexandra Kraus
Also filed as: KRAUS ALEXANDRA
4 granted patents·7 pending applications·13 citations·filing 2009–2024
67Inventor score
Files withNOVARTIS AG5IMMATICS BIOTECHNOLOGIES GMBH2MORPHOSYS AG2NXERA PHARMA UK LTD1WATERMAN ALISA1
Top patents by PatentIndex Score
11 records- 0183US11939397B2ENTPD2 antibodies, combination therapies, and methods of using the antibodies and combination therapiesNOVARTIS AG·Filed 2019·Granted Mar 26, 2024·3 cites·18 claims
- 0281US9090695B2Antibodies for guanylyl cyclase receptorsWATERMAN ALISA·Filed 2009·Granted Jul 28, 2015·10 cites·3 claims
- 0369US2024336701A1Entpd2 antibodies, combination therapies, and methods of using the antibodies and combination therapiesNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0459US2021024635A1Anti-wt1/hla-specific antibodiesIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Application pending·0 cites
- 0556US10836829B2Anti-WT1/HLA-specific antibodiesIMMATICS BIOTECHNOLOGIES GMBH·Filed 2016·Granted Nov 17, 2020·0 cites·13 claims
- 0654US2025313621A1Anti-par2 antibodiesNXERA PHARMA UK LTD·Filed 2023·Application pending·0 cites
- 0749US9873733B2Anti-staphylococcal antibodiesMORPHOSYS AG·Filed 2013·Granted Jan 23, 2018·0 cites·10 claims
- 0846US2022340685A1Combination therapy with entpd2 and cd73 antibodiesNOVARTIS AG·Filed 2020·Application pending·0 cites
- 0946US2022348651A1Entpd2 antibodies, combination therapies, and methods of using the antibodies and combination therapiesNOVARTIS AG·Filed 2020·Application pending·0 cites
- 1039US2016168251A1Antibodies for guanylyl cyclase receptorsMORPHOSYS AG·Filed 2015·Application pending·0 cites
- 1134US2010291106A1Compositions and methods for antibodies targeting complement protein c3bNOVARTIS AG·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Alexandra Kraus files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →